ALPHA TAU MEDICAL LTD. WARRANT reports a Return on Equity (ROE) of -82.01%.

What is DRTSW's dividend yield?

ALPHA TAU MEDICAL LTD. WARRANT offers a dividend yield of 0.00%.

What is DRTSW's Deepscope Quality Score?

Deepscope rates DRTSW's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy DRTSW?

Deepscope's AI Timing Score for DRTSW is 87 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

DRTSW (NASDAQ) 株価分析 | ALPHA TAU MEDICAL LTD. WARRANT

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

DRTSW

ALPHA TAU MEDICAL LTD. WARRANT

US:NASDAQ STOCK News 76

USD 2.00

-0.37 (-15.61%) Day Change

Watchlist Portfolio Compare Chart

0.11

D/E

-82.0%

ROE

-52.3%

ROA

0.00%

Div Yield

ALPHA TAU MEDICAL LTD. WARRANT
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 2.00 Price -0.37 (-15.61%) Day Change	NEWS SCORE: 76

DRTSW, ファンダメンタルスコアはnot good ( ファンダメンタル = 23) but テクニカルスコアは ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROEが低い
ROAが低い
平均ROEが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	76
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	2.00
PBV / Sector	N/A / N/A
Earning Per Share	N/A

PE / Sector	N/A / N/A
PEG or PE/Growth / Sector	N/A / N/A
Average 1M Daily Value	0.21 M GREAT
Average 1W Daily Value	0.10 M GREAT

Timing Factors

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

45%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / N/A
NPM Average (%) / Sector	N/A / N/A
NPM Change Average (%) / Sector	N/A / N/A
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-52.29 / N/A
ROA Average (%) / Sector	-36.87 / N/A
ROA Change Average (%) / Sector	17.90 / N/A GOOD
ROE (%) / Sector	-82.01 / N/A
ROE Average (%) / Sector	-50.89 / N/A
ROE Change Average (%) / Sector	28.06 / N/A GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

登録情報

Analyze Date	2026-06-06 09:09:23
Symbol	DRTSW
Name	ALPHA TAU MEDICAL LTD. WARRANT
Sector
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	N/A / N/A

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Kiryat HaMada St. 5, Jerusalem, Israel, 9777605

Phone: 972 3 577 4115

Website: https://www.alphatau.com

Employees: 121

Sector: -

Description: Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors. The company is headquartered in Jerusalem, Israel.